$PCOP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PHARMACOPEIA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PHARMACOPEIA INC. Get notifications about new insider transactions in PHARMACOPEIA INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 19.77 | 8,364 | 165,379 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 8.88 | 13,970 | 124,079 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 5.85 | 4,021 | 23,532 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 5.30 | 18,728 | 99,343 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 5.05 | 21,311 | 107,523 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 4.75 | 4,103 | 19,489 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 4.67 | 20,000 | 93,400 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 4.04 | 12,190 | 49,204 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 3.84 | 20,000 | 76,800 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 19.77 | 11,435 | 226,101 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 8.88 | 13,530 | 120,171 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 5.85 | 8,355 | 48,896 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 5.30 | 14,271 | 75,701 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 5.05 | 11,688 | 58,971 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 4.75 | 20,897 | 99,261 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Option Exercise | D | 4.04 | 18,609 | 75,113 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Sell | D | 0.00 | 17,701 | 0 | 0 | 17.7 K to 0 (-100.00 %) |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Payment of Exercise | F | 0.00 | 3,534 | 0 | 17,701 | 21.2 K to 17.7 K (-16.64 %) |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Soeters Martinus Hermanus | Director | Sell | D | 0.00 | 2,500 | 0 | 0 | 2.5 K to 0 (-100.00 %) |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 19.77 | 74 | 1,463 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 6.20 | 46,478 | 288,164 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 5.30 | 12,760 | 67,685 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 4.75 | 338 | 1,606 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 4.67 | 24,788 | 115,760 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 3.84 | 55,818 | 214,341 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 19.77 | 10,925 | 216,017 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 8.88 | 22,000 | 195,400 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 6.20 | 28,524 | 176,849 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 4.94 | 14,027 | 69,338 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 4.75 | 24,831 | 117,947 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 4.67 | 10,212 | 47,690 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 4.32 | 7,700 | 33,250 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | D | 3.84 | 24,182 | 92,859 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Sell | D | 0.00 | 39,814 | 0 | 0 | 39.8 K to 0 (-100.00 %) |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | MOLLICA JOSEPH A | Chairman, Interm-Pr ... | Sell | D | 0.00 | 141,977 | 0 | 0 | 142 K to 0 (-100.00 %) |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Option Exercise | D | 5.81 | 70,761 | 411,121 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Option Exercise | D | 4.75 | 21,484 | 102,049 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Option Exercise | D | 4.67 | 14,323 | 66,888 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Option Exercise | D | 3.84 | 39,609 | 152,099 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Option Exercise | D | 5.81 | 54,239 | 315,129 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Option Exercise | D | 4.75 | 9,766 | 46,389 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Option Exercise | D | 4.67 | 16,927 | 79,049 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Option Exercise | D | 3.84 | 40,391 | 155,101 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Sell | D | 0.00 | 66,007 | 0 | 0 | 66 K to 0 (-100.00 %) |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Option Exercise | D | 4.67 | 4,167 | 19,460 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Option Exercise | D | 3.95 | 100,000 | 395,000 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Option Exercise | D | 3.84 | 15,209 | 58,403 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Option Exercise | D | 3.63 | 21,000 | 76,230 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Option Exercise | D | 3.84 | 74,791 | 287,197 | 0 | |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Sell | D | 0.00 | 31,770 | 0 | 0 | 31.8 K to 0 (-100.00 %) |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Payment of Exercise | F | 0.00 | 11,780 | 0 | 31,770 | 43.6 K to 31.8 K (-27.05 %) |
| Dec 24 2008 | PCOP | PHARMACOPEIA INC | BARTLETT PAUL A | Director | Sell | D | 0.00 | 31,219 | 0 | 0 | 31.2 K to 0 (-100.00 %) |
| Nov 03 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Grant | A | 0.87 | 296 | 258 | 21,235 | 20.9 K to 21.2 K (+1.41 %) |
| Nov 03 2008 | PCOP | PHARMACOPEIA INC | MOLLICA JOSEPH A | Chairman, Interm-Pr ... | Grant | A | 0.87 | 1,125 | 979 | 141,977 | 140.9 K to 142 K (+0.80 %) |
| Oct 01 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Grant | A | 1.49 | 394 | 587 | 20,939 | 20.5 K to 20.9 K (+1.92 %) |
| Oct 01 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Grant | A | 1.49 | 112 | 167 | 39,814 | 39.7 K to 39.8 K (+0.28 %) |
| Oct 01 2008 | PCOP | PHARMACOPEIA INC | MOLLICA JOSEPH A | Chairman, Interm-Pr ... | Grant | A | 1.49 | 680 | 1,013 | 140,852 | 140.2 K to 140.9 K (+0.49 %) |
| Sep 26 2008 | PCOP | PHARMACOPEIA INC | AUSTIN JOSIAH T | 10% Owner | Buy | P | 1.18 | 70,000 | 82,502 | 4,109,964 | 4 M to 4.1 M (+1.73 %) |
| Sep 23 2008 | PCOP | PHARMACOPEIA INC | AUSTIN JOSIAH T | 10% Owner | Buy | P | 1.27 | 17,839 | 22,743 | 4,039,964 | 4 M to 4 M (+0.44 %) |
| Sep 15 2008 | PCOP | PHARMACOPEIA INC | AUSTIN JOSIAH T | 10% Owner | Buy | P | 1.67 | 95,000 | 158,185 | 4,022,125 | 3.9 M to 4 M (+2.42 %) |
| Sep 15 2008 | PCOP | PHARMACOPEIA INC | AUSTIN JOSIAH T | 10% Owner | Buy | P | 1.68 | 105,000 | 176,778 | 3,927,125 | 3.8 M to 3.9 M (+2.75 %) |
| Sep 11 2008 | PCOP | PHARMACOPEIA INC | AUSTIN JOSIAH T | 10% Owner | Buy | P | 1.70 | 21,600 | 36,815 | 3,822,125 | 3.8 M to 3.8 M (+0.57 %) |
| Sep 11 2008 | PCOP | PHARMACOPEIA INC | AUSTIN JOSIAH T | 10% Owner | Buy | P | 1.76 | 51,100 | 89,926 | 3,800,525 | 3.7 M to 3.8 M (+1.36 %) |
| Sep 05 2008 | PCOP | PHARMACOPEIA INC | AUSTIN JOSIAH T | 10% Owner | Buy | P | 1.99 | 124,633 | 247,446 | 3,749,425 | 3.6 M to 3.7 M (+3.44 %) |
| Sep 03 2008 | PCOP | PHARMACOPEIA INC | AUSTIN JOSIAH T | 10% Owner | Buy | P | 2.09 | 2,000 | 4,172 | 3,624,792 | 3.6 M to 3.6 M (+0.06 %) |
| Sep 03 2008 | PCOP | PHARMACOPEIA INC | AUSTIN JOSIAH T | 10% Owner | Buy | P | 2.09 | 2,000 | 4,172 | 3,624,792 | 3.6 M to 3.6 M (+0.06 %) |
| Sep 03 2008 | PCOP | PHARMACOPEIA INC | AUSTIN JOSIAH T | 10% Owner | Buy | P | 2.09 | 2,000 | 4,172 | 3,624,792 | 3.6 M to 3.6 M (+0.06 %) |
| Sep 03 2008 | PCOP | PHARMACOPEIA INC | AUSTIN JOSIAH T | 10% Owner | Buy | P | 2.08 | 2,000 | 4,168 | 3,624,792 | 3.6 M to 3.6 M (+0.06 %) |
| Sep 02 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Grant | A | 2.10 | 280 | 588 | 20,545 | 20.3 K to 20.5 K (+1.38 %) |
| Sep 02 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Grant | A | 2.10 | 296 | 622 | 39,702 | 39.4 K to 39.7 K (+0.75 %) |
| Sep 02 2008 | PCOP | PHARMACOPEIA INC | MOLLICA JOSEPH A | Chairman, Interm-Pr ... | Grant | A | 2.10 | 482 | 1,012 | 140,173 | 139.7 K to 140.2 K (+0.35 %) |
| Sep 02 2008 | PCOP | PHARMACOPEIA INC | KIMBALL DAVID | SVP, Discovery | Grant | A | 2.10 | 316 | 664 | 37,011 | 36.7 K to 37 K (+0.86 %) |
| Sep 02 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Grant | A | 2.10 | 120 | 252 | 66,007 | 65.9 K to 66 K (+0.18 %) |
| Aug 01 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Grant | A | 3.27 | 180 | 589 | 20,265 | 20.1 K to 20.3 K (+0.90 %) |
| Aug 01 2008 | PCOP | PHARMACOPEIA INC | MOLLICA JOSEPH A | Chairman, Int.-Pres ... | Grant | A | 3.27 | 310 | 1,014 | 139,690 | 139.4 K to 139.7 K (+0.22 %) |
| Aug 01 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Grant | A | 3.27 | 190 | 621 | 39,406 | 39.2 K to 39.4 K (+0.48 %) |
| Aug 01 2008 | PCOP | PHARMACOPEIA INC | KIMBALL DAVID | SVP, Discovery | Grant | A | 3.27 | 203 | 664 | 36,695 | 36.5 K to 36.7 K (+0.56 %) |
| Aug 01 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Grant | A | 3.27 | 201 | 657 | 65,887 | 65.7 K to 65.9 K (+0.31 %) |
| Aug 01 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Grant | A | 3.27 | 141 | 461 | 43,550 | 43.4 K to 43.6 K (+0.32 %) |
| Aug 01 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Grant | A | 3.83 | 171 | 655 | 40,686 | 40.5 K to 40.7 K (+0.42 %) |
| Aug 01 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Grant | A | 3.83 | 201 | 770 | 43,408 | 43.2 K to 43.4 K (+0.47 %) |
| Jul 28 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Grant | A | 0.00 | 25,000 | 0 | 65,686 | 40.7 K to 65.7 K (+61.45 %) |
| Jul 01 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Grant | A | 3.83 | 153 | 586 | 20,085 | 19.9 K to 20.1 K (+0.77 %) |
| Jul 01 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Grant | A | 3.83 | 162 | 620 | 39,215 | 39.1 K to 39.2 K (+0.41 %) |
| Jul 01 2008 | PCOP | PHARMACOPEIA INC | KIMBALL DAVID | SVP, Discovery | Grant | A | 3.83 | 173 | 663 | 36,491 | 36.3 K to 36.5 K (+0.48 %) |
| Jul 01 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Grant | A | 3.83 | 171 | 655 | 40,686 | 40.5 K to 40.7 K (+0.42 %) |
| Jul 01 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Grant | A | 3.83 | 201 | 770 | 43,408 | 43.2 K to 43.4 K (+0.47 %) |
| Jul 01 2008 | PCOP | PHARMACOPEIA INC | MOLLICA JOSEPH A | Chairman, Interm-Pr ... | Grant | A | 3.83 | 414 | 1,586 | 139,381 | 139 K to 139.4 K (+0.30 %) |
| Jun 02 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Grant | A | 4.31 | 178 | 767 | 43,208 | 43 K to 43.2 K (+0.41 %) |
| Jun 02 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Grant | A | 4.31 | 152 | 655 | 40,515 | 40.4 K to 40.5 K (+0.38 %) |
| Jun 02 2008 | PCOP | PHARMACOPEIA INC | Liebler Eric J | EVP Corporate Devel ... | Grant | A | 4.31 | 161 | 694 | 56,048 | 55.9 K to 56 K (+0.29 %) |
| Jun 02 2008 | PCOP | PHARMACOPEIA INC | KIMBALL DAVID | SVP, Discovery | Grant | A | 4.31 | 154 | 664 | 36,318 | 36.2 K to 36.3 K (+0.43 %) |
| Jun 02 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Grant | A | 4.31 | 144 | 621 | 39,053 | 38.9 K to 39.1 K (+0.37 %) |
| Jun 02 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Grant | A | 4.31 | 136 | 586 | 19,932 | 19.8 K to 19.9 K (+0.69 %) |
| May 09 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Grant | A | 0.00 | 12,000 | 0 | 19,795 | 7.8 K to 19.8 K (+153.94 %) |
| Jun 02 2008 | PCOP | PHARMACOPEIA INC | MOLLICA JOSEPH A | Chairman, Interm-Pr ... | Grant | A | 4.31 | 266 | 1,146 | 138,967 | 138.7 K to 139 K (+0.19 %) |
| May 09 2008 | PCOP | PHARMACOPEIA INC | MOLLICA JOSEPH A | Chairman, Interm-Pr ... | Grant | A | 0.00 | 55,000 | 0 | 138,700 | 83.7 K to 138.7 K (+65.71 %) |
| May 09 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Grant | A | 0.00 | 30,000 | 0 | 38,909 | 8.9 K to 38.9 K (+336.74 %) |
| May 09 2008 | PCOP | PHARMACOPEIA INC | Liebler Eric J | EVP Corporate Devel ... | Grant | A | 0.00 | 35,000 | 0 | 55,887 | 20.9 K to 55.9 K (+167.57 %) |
| May 09 2008 | PCOP | PHARMACOPEIA INC | KIMBALL DAVID | SVP, Discovery | Grant | A | 0.00 | 35,000 | 0 | 36,164 | 1.2 K to 36.2 K (+3,006.87 %) |
| May 09 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Grant | A | 0.00 | 35,000 | 0 | 40,363 | 5.4 K to 40.4 K (+652.62 %) |
| May 09 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Grant | A | 0.00 | 40,000 | 0 | 43,030 | 3 K to 43 K (+1,320.13 %) |
| May 02 2008 | PCOP | PHARMACOPEIA INC | TOMLINSON SIMON M | SVP, Business Devel ... | Grant | A | 3.35 | 235 | 787 | 6,130 | 5.9 K to 6.1 K (+3.99 %) |
| May 02 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Grant | A | 3.35 | 175 | 586 | 7,795 | 7.6 K to 7.8 K (+2.30 %) |
| May 02 2008 | PCOP | PHARMACOPEIA INC | Soeters Martinus Hermanus | Director | Option Exercise | A | 3.35 | 15,000 | 50,250 | 15,000 | |
| May 02 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Grant | A | 3.35 | 186 | 623 | 8,909 | 8.7 K to 8.9 K (+2.13 %) |
| May 02 2008 | PCOP | PHARMACOPEIA INC | PEACOCK BRUCE | Director | Option Exercise | A | 3.35 | 15,000 | 50,250 | 15,000 | |
| May 02 2008 | PCOP | PHARMACOPEIA INC | Liebler Eric J | EVP Corporate Devel ... | Grant | A | 3.35 | 207 | 693 | 20,887 | 20.7 K to 20.9 K (+1.00 %) |
| May 02 2008 | PCOP | PHARMACOPEIA INC | Liebler Eric J | EVP Corporate Devel ... | Grant | A | 3.35 | 207 | 693 | 20,887 | 20.7 K to 20.9 K (+1.00 %) |
| May 02 2008 | PCOP | PHARMACOPEIA INC | LANGER DENNIS | Director | Option Exercise | A | 3.35 | 15,000 | 50,250 | 15,000 | |
| May 02 2008 | PCOP | PHARMACOPEIA INC | KIMBALL DAVID | SVP, Discovery | Grant | A | 3.35 | 198 | 663 | 1,164 | 966 to 1.2 K (+20.50 %) |
| May 02 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Grant | A | 3.35 | 196 | 657 | 5,363 | 5.2 K to 5.4 K (+3.79 %) |
| May 02 2008 | PCOP | PHARMACOPEIA INC | Burakoff Steven J | Director | Option Exercise | A | 3.35 | 15,000 | 50,250 | 15,000 | |
| May 02 2008 | PCOP | PHARMACOPEIA INC | Browne Leslie J | President and CEO | Grant | A | 3.35 | 98 | 328 | 14,549 | 14.5 K to 14.5 K (+0.68 %) |
| May 02 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Grant | A | 3.35 | 229 | 767 | 3,030 | 2.8 K to 3 K (+8.18 %) |
| May 02 2008 | PCOP | PHARMACOPEIA INC | BARTLETT PAUL A | Director | Option Exercise | A | 3.35 | 15,000 | 50,250 | 15,000 | |
| May 02 2008 | PCOP | PHARMACOPEIA INC | BALDINO FRANK JR | Director | Option Exercise | A | 3.35 | 15,000 | 50,250 | 15,000 | |
| May 02 2008 | PCOP | PHARMACOPEIA INC | AMMON CAROL A | Director | Option Exercise | A | 3.35 | 15,000 | 50,250 | 15,000 | |
| Apr 02 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Grant | A | 3.65 | 714 | 2,606 | 5,167 | 4.5 K to 5.2 K (+16.03 %) |
| Apr 02 2008 | PCOP | PHARMACOPEIA INC | Floyd David M | EVP, Chief Scientif ... | Grant | A | 3.65 | 862 | 3,146 | 5,085 | 4.2 K to 5.1 K (+20.41 %) |
| Apr 02 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Grant | A | 3.65 | 622 | 2,270 | 8,723 | 8.1 K to 8.7 K (+7.68 %) |
| Apr 02 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Preclinical Res ... | Grant | A | 3.65 | 506 | 1,847 | 7,620 | 7.1 K to 7.6 K (+7.11 %) |
| Apr 02 2008 | PCOP | PHARMACOPEIA INC | TOMLINSON SIMON M | SVP, Business Devel ... | Grant | A | 3.65 | 515 | 1,880 | 5,895 | 5.4 K to 5.9 K (+9.57 %) |
| Apr 02 2008 | PCOP | PHARMACOPEIA INC | Liebler Eric J | EVP Corporate Devel ... | Grant | A | 3.65 | 334 | 1,219 | 20,680 | 20.3 K to 20.7 K (+1.64 %) |
| Apr 02 2008 | PCOP | PHARMACOPEIA INC | KIMBALL DAVID | SVP, Discovery | Option Exercise | A | 3.63 | 40,000 | 145,200 | 40,000 | |
| Apr 02 2008 | PCOP | PHARMACOPEIA INC | KIMBALL DAVID | SVP, Discovery | Grant | A | 3.65 | 269 | 982 | 966 | 697 to 966 (+38.59 %) |
| Apr 02 2008 | PCOP | PHARMACOPEIA INC | Browne Leslie J | President and CEO | Grant | A | 3.65 | 1,202 | 4,387 | 14,452 | 13.3 K to 14.5 K (+9.07 %) |
| Apr 02 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Option Exercise | A | 3.63 | 21,000 | 76,230 | 21,000 | |
| Apr 02 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | SVP, Clinical & Reg ... | Grant | A | 3.65 | 712 | 2,599 | 2,800 | 2.1 K to 2.8 K (+34.10 %) |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Drug Discovery ... | Option Exercise | A | 3.84 | 20,000 | 76,800 | 20,000 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | WEBB MARIA L | VP, Drug Discovery ... | Grant | A | 3.68 | 152 | 559 | 7,114 | 7 K to 7.1 K (+2.18 %) |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | TOMLINSON SIMON M | SVP, Business Devel ... | Option Exercise | A | 3.84 | 22,000 | 84,480 | 22,000 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | TOMLINSON SIMON M | SVP, Business Devel ... | Grant | A | 3.68 | 157 | 578 | 5,381 | 5.2 K to 5.4 K (+3.01 %) |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | A | 3.84 | 55,818 | 214,341 | 55,818 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Option Exercise | A | 3.84 | 24,182 | 92,859 | 24,182 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | POSNER BRIAN M | EVP, CFO | Grant | A | 3.68 | 163 | 600 | 8,101 | 7.9 K to 8.1 K (+2.05 %) |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Liebler Eric J | EVP Corporate Devel ... | Option Exercise | A | 3.84 | 33,000 | 126,720 | 33,000 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Liebler Eric J | EVP Corporate Devel ... | Grant | A | 3.68 | 187 | 688 | 20,346 | 20.2 K to 20.3 K (+0.93 %) |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | KIMBALL DAVID | SVP Chemistry and P ... | Option Exercise | A | 3.84 | 5,500 | 21,120 | 5,500 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | KIMBALL DAVID | SVP Chemistry and P ... | Grant | A | 3.68 | 170 | 626 | 697 | 527 to 697 (+32.26 %) |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Option Exercise | A | 3.84 | 39,609 | 152,099 | 39,609 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Option Exercise | A | 3.84 | 40,391 | 155,101 | 40,391 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Costalas Stephen C | EVP, General Counse ... | Grant | A | 3.68 | 171 | 629 | 4,453 | 4.3 K to 4.5 K (+3.99 %) |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Floyd David M | EVP, Chief Scientif ... | Grant | A | 3.68 | 207 | 762 | 4,223 | 4 K to 4.2 K (+5.15 %) |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Browne Leslie J | President and CEO | Option Exercise | A | 3.84 | 74,859 | 287,459 | 74,859 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Browne Leslie J | President and CEO | Option Exercise | A | 3.84 | 25,141 | 96,541 | 25,141 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Browne Leslie J | President and CEO | Grant | A | 3.68 | 268 | 986 | 13,250 | 13 K to 13.3 K (+2.06 %) |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | VP Clinical & Regul ... | Option Exercise | A | 3.84 | 15,209 | 58,403 | 15,209 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | VP Clinical & Regul ... | Option Exercise | A | 3.84 | 74,791 | 287,197 | 74,791 | |
| Mar 04 2008 | PCOP | PHARMACOPEIA INC | Belder Rene | VP Clinical & Regul ... | Grant | A | 3.68 | 188 | 692 | 2,088 | 1.9 K to 2.1 K (+9.89 %) |